Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

First patient enrolled in phase I/II study of TheraCIM hR3 for pediatric glioma

June 17, 2004

ZYC-101a shows 100% efficacy in patients with high-grade cervical dysplasia

June 17, 2004

Antitumor effects and safety of rhLF in advanced cancer patients

June 17, 2004

Novogen patent discloses isoflavonoid-based antiproliferative agents

June 16, 2004

New antitumor agents developed by Sanofi-Synthelabo scientists

June 16, 2004

Two series of mitotic kinesin KSP inhibitors claimed by Merck

June 16, 2004

Delayed tumor progression found with atrasentan in prostate cancer

June 16, 2004

ARRY-142886 enters phase I trial for advanced cancer

June 16, 2004

A6 enters phase II trial to prevent clinical relapse in ovarian cancer patients

June 16, 2004

Aptosyn phase III study in NSCLC fails to meet endpoints

June 16, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Latus Bio series A financing supports early-stage programs
BioWorld Science
Latus Bio Inc. has closed a $97 million series A financing to support its broad therapeutics pipeline based on novel AAV capsid variants. Proceeds from the...